BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $798,220 | +138.9% | 30,270 | +55.8% | 0.00% | +200.0% |
Q2 2023 | $334,110 | +3612.3% | 19,425 | +1778.6% | 0.00% | – |
Q2 2022 | $9,000 | -25.0% | 1,034 | -8.8% | 0.00% | – |
Q1 2022 | $12,000 | +33.3% | 1,134 | +102.1% | 0.00% | – |
Q4 2021 | $9,000 | -57.1% | 561 | +25.5% | 0.00% | – |
Q3 2021 | $21,000 | +90.9% | 447 | +149.7% | 0.00% | – |
Q2 2021 | $11,000 | -15.4% | 179 | -12.3% | 0.00% | – |
Q1 2021 | $13,000 | – | 204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |